In the sandbox: palliative care and hematologic malignancies.
Publication
, Journal Article
LeBlanc, TW
Published in: J Community Support Oncol
February 2014
Palliative care specialists have had little involvement in the care of patients with hematologic malignancies. The reasons for this are not clear, because these patients certainly face a significant symptom burden, and many hematologic malignancies are either incurable or carry poor prognoses. For example, acute myeloid leukemia (AML) in patients over age 60 has a 5-year survival of less than 10%, akin to pancreatic cancer. Although most oncologists would agree with involving palliative care specialists in the case of advanced pancreatic cancer, few seem to consider this in the context of AML. Why should AML be any different?
Duke Scholars
Published In
J Community Support Oncol
DOI
ISSN
2330-7749
Publication Date
February 2014
Volume
12
Issue
2
Start / End Page
44 / 45
Location
United States
Related Subject Headings
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
LeBlanc, T. W. (2014). In the sandbox: palliative care and hematologic malignancies. J Community Support Oncol, 12(2), 44–45. https://doi.org/10.12788/jcso.0012
LeBlanc, Thomas W. “In the sandbox: palliative care and hematologic malignancies.” J Community Support Oncol 12, no. 2 (February 2014): 44–45. https://doi.org/10.12788/jcso.0012.
LeBlanc TW. In the sandbox: palliative care and hematologic malignancies. J Community Support Oncol. 2014 Feb;12(2):44–5.
LeBlanc, Thomas W. “In the sandbox: palliative care and hematologic malignancies.” J Community Support Oncol, vol. 12, no. 2, Feb. 2014, pp. 44–45. Pubmed, doi:10.12788/jcso.0012.
LeBlanc TW. In the sandbox: palliative care and hematologic malignancies. J Community Support Oncol. 2014 Feb;12(2):44–45.
Published In
J Community Support Oncol
DOI
ISSN
2330-7749
Publication Date
February 2014
Volume
12
Issue
2
Start / End Page
44 / 45
Location
United States
Related Subject Headings
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis